M. Homsanit, S. Sriussadaporn; S. Vannasaeng; T. Peerapatdit; W. Nitiyanant; A. Vichayanrat, Efficacy of single daily dosage of methimazole vs. propylthiouracil in the induction of euthyroidism., in Clin Endocrinol (Oxf), vol. 54, n. 3, Mar 2001, pp. 385-90, PMID 11298092.
JH. Lazarus, B. Marchant; WD. Alexander; DH. Clark, 35-S-antithyroid drug concentration and organic binding of iodine in the human thyroid., in Clin Endocrinol (Oxf), vol. 4, n. 6, Nov 1975, pp. 609-15, PMID 53111.
WD. Alexander, V. Evans; A. MacAulay; TF. Gallagher; J. Londono, Metabolism of 35S-labelled antithyroid drugs in man., in Br Med J, vol. 2, n. 5652, maggio 1969, pp. 290-1, PMID 4180995.
JP. Kampmann, JM. Hansen, Clinical pharmacokinetics of antithyroid drugs., in Clin Pharmacokinet, vol. 6, n. 6, pp. 401-28, PMID 6172233.
D. Kozielewicz, K. Karwowska; D. Dybowska; W. Halota, Agranulocytosis during treatment of chronic hepatitis C complicated by hyperthyreosis. Case reports., in Endokrynol Pol, vol. 63, n. 1, 2012, pp. 52-5, PMID 22378098.
R. Ohwada, K. Kato; K. Ohmori; O. Isozaki; M. Hotta; M. Ono; K. Takano, A man with interstitial pneumonia due to propylthiouracil., in Intern Med, vol. 42, n. 10, Oct 2003, pp. 1026-30, PMID 14606720.
Y. Ichiki, M. Akahoshi; N. Yamashita; C. Morita; T. Maruyama; T. Horiuchi; K. Hayashida; H. Ishibashi; Y. Niho, Propylthiouracil-induced severe hepatitis: a case report and review of the literature., in J Gastroenterol, vol. 33, n. 5, Oct 1998, pp. 747-50, PMID 9773944.
XL. Lian, Y. Bai; WX. Dai; ZM. Jin; ZP. Zeng; ZS. Guo, [The clinical characteristics of symptomatic propylthiouracil-induced hepatic injury in patients with hyperthyroidism]., in Zhonghua Nei Ke Za Zhi, vol. 43, n. 6, Jun 2004, pp. 442-6, PMID 15312442.
E. Memi, S. Karras; T. Tzotzas; GE. Krassas, Propylthiouracil hepatitis: report of a case and extensive review of the literature., in J Pediatr Endocrinol Metab, vol. 25, n. 3-4, 2012, pp. 331-43, PMID 22768665.